Peptide Companion
Back to catalog
Peptide Companion
single
Sexual Health
Vial: 2 mg

Gonadorelin (2 mg Vial)

Gonadorelin dosage supports the restoration of natural LH and FSH release from the pituitary gland, reactivating the hypothalamic‑pituitary‑gonadal (HPG) axis. As a synthetic form of gonadotropin‑releasing hormone (GnRH), gonadorelin stimulates testosterone production in men and promotes ovulation in women when administered in short, pulsatile doses. This educational protocol outlines a subcutaneous micro‑dosing approach using a practical dilution for accurate insulin‑syringe measurements.

Dose
0.1–0.2 mg per injection
Frequency
2–3 times weekly
Timing
Any time of day
Duration
Research protocol specific

Stimulates LH/FSH release. HPG axis research. Pulsatile administration may be beneficial.

Dosing Schedule
Week/PhaseDose per Injection (mcg)Units (mL)
Weeks 1–2 (Initiation)50 mcg5 units (0.05 mL)
Weeks 3–4 (Titration)100 mcg10 units (0.10 mL)
Weeks 5–8 (Maintenance)100–150 mcg10–15 units (0.10–0.15 mL)
Supplies Needed
  • •Peptide Vials (Gonadorelin, 2 mg each):
  • •Insulin Syringes (U‑100, 30‑ or 50‑unit preferred):
  • •Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
References

  • PubMed

    GnRH agonists: gonadorelin, leuprolide, and nafarelin – overview of pharmacology and clinical applications

    View source

  • Mayo Clinic

    Gonadorelin injection routes and indications for LH/FSH stimulation testing

    View source

  • Wikipedia

    Gonadorelin pharmacology, pulsatile dosing, and clinical history

    View source

  • PMC

    Gonadotropin‑releasing hormone analogs: pulsatile vs. continuous effects on FSH/LH

    View source

  • PubMed

    Gonadotropin treatment for male hypogonadotropic hypogonadism – spermatogenesis and fertility

    View source

  • ScienceDirect

    Gonadorelin agonist overview: initial stimulation and subsequent down‑regulation mechanisms

    View source

  • PMC

    Preserving fertility in the hypogonadal patient: hCG and GnRH therapy options

    View source

  • PMC

    Pulsatile gonadorelin pump induces earlier spermatogenesis in congenital HH men

    View source

  • PubMed

    Application of GnRH in hypogonadotropic hypogonadism: diagnostic and therapeutic aspects

    View source

  • Drugs.com

    Gonadorelin injectable: uses, side effects, and warnings

    View source

  • PMC

    Subcutaneous drug injection review: pharmacologic considerations

    View source

  • CDC

    Vaccine administration: subcutaneous route (angle/site; no aspiration)

    View source

  • CDC (Subcut Injection PDF)

    Technique diagram and site guidance for subcutaneous injections

    View source

  • NCBI Bookshelf

    Best practices for injection (asepsis, preparation, and administration)

    View source

Educational content adapted from peptidedosages.com. Not medical advice.